Hims & Hers Health, Inc. (HIMS)

Market Cap	6.47B -39.7%
Revenue (ttm)	2.58B +28.0%
Net Income	-142.03M
EPS	-0.62
Shares Out	233.31M
PE Ratio	n/a
Forward PE	80.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,827,824
Open	28.85
Previous Close	29.13
Day's Range	27.30 - 28.91
52-Week Range	13.74 - 50.99
Beta	2.43
Analysts	Hold
Price Target	31.15 (+12.41%)
Earnings Date	Nov 9, 2026

About HIMS

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Employees: 2,442
• Stock Exchange: NYSE
• Ticker Symbol: HIMS
• Website: https://www.hims.com

Financial Performance

In 2025, Hims & Hers Health's revenue was $2.35 billion, an increase of 59.00% compared to the previous year's $1.48 billion. Earnings were $128.37 million, an increase of 1.85%.

Analyst Summary

According to 15 analysts, the average rating for HIMS stock is "Hold." The 12-month stock price target is $31.15, which is an increase of 12.41% from the latest price.

Price Target

$31.15

(12.41% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 24, 2026

Data Sources Report a data error